medigraphic.com
ISSN 0016-3813 (Impreso)

2014, Número 1

<< Anterior Siguiente >>

Gac Med Mex 2014; 150 (1)


Melanoma primario múltiple (MMP) sincrónico: caso clínico y revisión de la literatura

Solís-Arias MP, Lammoglia-Ordiales L, Toussaint-Caire S, Galván-Martínez I, Fonte-Ávalos V

Idioma: Español
Referencias bibliográficas: 31
Paginas: 101-105
Archivo PDF: 273.42 Kb.


RESUMEN

Los pacientes con diagnóstico de melanoma tienen mayor riesgo de desarrollar nuevos melanomas primarios. Se presenta el caso de un paciente masculino de 42 años con diagnóstico de MMP sincrónico que acudió al Servicio de Dermatología del Hospital General Dr. Manuel Gea González de la Ciudad de México. En esta revisión se discuten la incidencia, los factores de riesgo y el pronóstico de estos pacientes.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Halder RM, Ara CJ. Skin cancer and photoaging in ethnic skin. Dermatol Clin. 2003;21:725-32.

  2. Káram M, Toussaint S, Domínguez J, Vega E. Características clínicas e histopatológicas del melanoma maligno en el Hospital General «Dr. Manuel Gea González». Gac Méd Méx. 2008;144(3):219-23.

  3. Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE 3rd, et al. Trisal VNational Comprehensive Cancer Network (NCCN). Melanoma, version 2.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2013 Apr 1;11(4):395-407.

  4. Slingluff CL Jr, Vollmer RT, SeiglerHF. Multiple primary melanoma: incidence and risk factors in 283 patients. Surgery. 1993;113:330-9.

  5. Johnson TM, Hamilton T, Lowe L. Multiple primary melanomas. J Am Acad Dermatol. 1998;39:422-7.

  6. Ferrone CR, Ben Porat L, Panageas KS, et al. Clinicopathological features of and risk factors for multiple primary melanomas. JAMA. 2005;294(13):1647-54.

  7. DiFronzo LA, Wanek LA, Elashoff R, Morton DL. Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma. Ann Surg Oncol. 1999;6:705-11.

  8. Titus-Ernstoff L, Perry AE, Spencer SK, et al. Multiple primary melanoma: two-year results from a population-based study. Arch Dermatol. 2006;142(4):433-8.

  9. Ferreres JR, Moreno A, Marcoval J. Multiple primary melanoma. Actas Dermosifiliogr. 2009;100(5):414-9.

  10. Blackwood MA, Holmes R, Synnestvedt M, et al. Multiple primary melanoma revisited. Cancer. 2002;94:2248-55.

  11. DiFronzo LA, Wanek LA, Morton DL. Earlier diagnosis of second primary melanoma confirms the benefits of patient education and routine postoperative follow-up. Cancer. 2001;91:1520-4.

  12. Brobeil A, Rapaport D, Wells K, et al. Multiple primary melanomas: implications for screening and follow- up programs for melanoma. Ann Surg Oncol. 1997;4:19-23.

  13. Hwa C, Price LS, Belitskaya-Levy I, et al. Single versus multiple primary melanomas: Old questions and new answers. Cancer. 2012;118 (17):4184-92.

  14. de Giorgi V, Rossari S, Papi F, et al. Multiple primary melanoma: the impact of atypical naevi and follow up. Br J Dermatol. 2010;163:1319-22.

  15. Doubrovsky A, Menzies SW. Enhanced survival in patients with multiple primary melanoma. Arch Dermatol. 2003;139:1013-8.

  16. Hughes-Davies TH. CDKN2A mutations in multiple primary melanomas. N Engl J Med. 1998;339:347-8.

  17. Puig S, Malvehy J, BAdenas C, Ruiz A, Jimenez D, Milà M. Role of the CDKN2Alocus in patients with multiple primary melanomas. J Clin Oncol. 2005 ;23(13):3043-51.

  18. Berwick M, Orlow I, Hummer AJ, et al. The prevalence of CDKN2A germline mutations and relative risk for cutaneous malignant melanoma: an international population-based study.CancerEpidemiol Biomarkers Prev. 2006;15:1520-5.

  19. Saleh FH, Crotty KA, Hersey P, Menzies SW. Primary melanoma tumour regression associated with an immune response to the tumour-associated antigen melan-A/MART-1. Int J Cancer. 2001;94:551-7.

  20. Zoller L, Mayer E, Itzhak OB, Bergman R. A lack of significantly increased incidence of regression in second primary melanomas does not support an ‘immunization effect’. J Cutan Pathol. 2010;37:1140-4.

  21. Giles G, Staples M, McCredie M, Coates M. Multiple primary melanomas: an analysis of cancer registry data from Victoria and New South Wales. Melanoma Res. 1995;5:433-8.

  22. Betti R, Gualandri L, Vergani R, Menni S, Crosti C. Really synchronous cutaneous melanomas: serendipity or need for prevention? Eur J Dermatol. 2009;19:258-9.

  23. Carli P, De Giorgi V, Chiarugi A, Stante M, Giannotti B. Multiple synchronous cutaneous melanomas: implications for prevention. Int J Dermatol. 2002;41(9):583-5.

  24. McCaul KA, Fritschi L, Baade P, Coory M. The incidence of second primary invasive melanoma in Queensland, 1982-2003. Cancer Causes Control. 2008;19:451-8.

  25. Carey WP, Thompson CJ, Synnestvedt M, et al. Dysplastic nevi as a melanoma risk factor in patients with familial melanoma. Cancer. 1994;74:3118-25.

  26. Stam-Posthuma JJ, van Duinen C, Scheffer E, Vink J, Bergman W. Multiple primary melanomas J Am Acad Dermatol. 2001;44:22-7.

  27. Burden AD, Newell J, Andrew N, Kavanagh G, Connor JM, MacKie RM. Genetic and environmental influences in the development of multiple primary melanoma. Arch Dermatol. 1999;135(3):261-5.

  28. Siskind V, Hughes MC, Palmer JM, et al. Nevi, familyhistory, and fairskinincrease the risk of second primary melanoma. J Invest Dermatol. 2011;131(2):461-7.

  29. Pack GT, Scharnagel IM, Hillyer RA. Multiple primary melanoma: a report of sixteen cases. Cancer. 1952;5:1110-5.

  30. Uliasz A, Lebwohl M. Patient education and regular surveillance results in earlier diagnosis of second primary melanoma.Int J Dermatol. 2007;46(6):575-7.

  31. Brobeil A, Rapaport D, Wells K, et al. Multiple primary melanomas: implications for screening and follow-up programs for melanoma. Ann Surg Oncol. 1997;4:19-23.




2020     |     www.medigraphic.com